Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
-
Biotechnology | Imaging | Medical Device | Neurology | Non-Profit Research | Oncology | Therapeutics
UVA Radiology Professors Develop New Focused Ultrasound Approach for Brain Tumors
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
-
Argenx to Acquire Forte Biosciences for $2.2 billion
On Jul. 27, 2026, argenx, a global immunology innovation company, and Dallas-based Forte Biosciences announced that the companies…
-
Ebola infections in DR Congo surge to 3,200, with 1,405 deaths
On Jul. 27, 2026, the number of people infected with Ebola in the Democratic Republic of the Congo…
-
FDA Approves Tylenol Nonprescription Fixed-Dose Combination of Acetaminophen and Naproxen Sodium for 12-Hour Pain Relief
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
-
US CDC links four more states to cyclosporiasis outbreak, Washington Post reports
On Jul. 24, 2026, The U.S. Centers for Disease Control and Prevention has linked four additional states to…
-
Biotechnology | Disease | HIV | Therapeutics | WHO
Merck licenses experimental HIV pill to generic makers in 129 countries
On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
-
U.S. FDA investigates another cyclosporiasis outbreak
On Jul. 22, 2026, The U.S. Food and Drug Administration (FDA) announced it is investigating a new outbreak…
-
Ebola death toll in Congo Exceeds 930, including dozens of health workers
On Jul. 20, 2026, the death toll in Congo’s Ebola outbreak has risen to at least 930, the…
-
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
-
Feinstein Institutes technology that restores movement and sensation after paralysis Published in Nature Medicine
On Jul. 16, 2026, the Feinstein Institutes for Medical Research announced findings featured in Nature Medicine demonstrating that…
-
Lilly to acquire AtaiBeckley for $3.8 billion advancing therapies for treatment-resistant depression
On Jul. 16, 2026, Eli Lilly and AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health…
-
Merck’s LIPFENDRA® (enlicitide) Approved by the FDA to Reduce Cholesterol
On Jul. 16, 2026, Merck announced the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA® (enlicitide) tablets…
-
FDA approves gedatolisib with fulvestrant, with or without palbociclib, for HR-positive, HER2-negative locally advanced or metastatic breast cancer
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
-
MIT engineers find a precise way to grow artificial blood vessels
On Jul. 14, 2026, Massachusetts Institute of Technology (MIT) engineers announced they have found they can engineer and…
-
CDC Reports 1,645 confirmed Cyclosporiasis Cases in Multiple U.S. States, 600% increase over Last Year
On Jul. 14, 2026, the Centers for Disease Control and Prevention announced it is notifying clinicians, public health…
-
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
On Jul. 13, 2026, Eisai Co. and Biogen announced that the U.S. Food and Drug Administration (FDA) has…
-
NYC Health Department Releases List of Buildings Ordered To Clean and Disinfect Their Cooling Towers for Legionnaires Disease
On Jul. 10, 2026, The NYC Health Department released, for the first time, a preliminary list of 31…
-
U.S. Cyclospora cases mount as CDC lags on tracking
On Jul. 9, 2026, the Center for Infectious Disease Research & Policy reported that in parts of the…
-
Researchers discover new form of hereditary prostate cancer
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
-
Surgeons Use Teleoperated Humanoid Robots to Perform Live Surgery – a World First
On Jul. 8, 2026, a team of surgeons at the University of California San Diego report that for…
-
Ebola continues to spread in DRC as death toll passes 500, WHO warns
On Jul. 7, 2026, the World Health Organization (WHO) reported that the outbreak of the deadly Bundibugyo species of…
-
Biotechnology | Disease | FDA | Therapeutics
US FDA approves Vera’s kidney disease drug
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
-
Novartis to acquire Myricx Bio for $1.5 Billion
On Jul. 6, 2026, Novartis announced it has reached an agreement to acquire Myricx Bio for up to…
-
Immunotherapy shows promise in treating deadly brain tumours
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
-
World’s first synthetic cell with a complete life cycle could revolutionize biological engineering
On Jul. 1, 2026, Associate Professors Kate Adamala and Aaron Engelhart and their teams at the College of…
-
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery Worth $600 million
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
